Related Experiment Video
Updated: Jul 15, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
[Necrotizing fasciitis in a patient during interferon-alpha treatment for hepatitis C virus infection: case report]
Beata Walkowiak1, Ryszard Zaba, Zbigniew Zaba
1Katedra i Klinika Dermatologii Akademii Medycznej im. K. Marcinkowskiego ul. Przybyszewskiego 49, 60-355 Poznań.
Abstract:
Necrotizing fascitis (NF) is a rare disease with a mortality rate ranging from 24 to 60 percent. The infection may be mono- or polymicrobial and is characterized by extensive necrosis of the skin and muscle, as well as fascia and subcutaneous tissue. NF may develop at the site of injury, e.g. trauma, needle puncture, or surgical incision. The lower extremities, perineum, and abdominal wall are common sites of NF. The remaining 10 percent of cases occur in the upper extremities or neck, usually in patients with vascular disease or diabetes mellitus. The course is rapidly progressive and may be life-threatening if the diagnosis is not made promptly and appropriate surgical debridement is not carried out. We report on a 44-year-old man with necrotizing fascitis during interferon-alpha treatment for hepatitis C virus infection.
Insights
Necrotizing fasciitis (NF) is a severe, rapidly progressing infection with high mortality. This case highlights a rare instance of NF developing during interferon-alpha therapy for hepatitis C.
Area of Science:
- Infectious Diseases
- Hepatology
- Dermatology
Background:
- Necrotizing fasciitis (NF) is a rare but life-threatening soft tissue infection.
- Characterized by extensive necrosis of skin, fascia, and muscle, NF has a high mortality rate (24-60%).
- Prompt diagnosis and surgical debridement are critical for patient survival.
Observation:
- The study presents a case of a 44-year-old male patient.
- The patient developed necrotizing fasciitis while undergoing interferon-alpha treatment for hepatitis C virus infection.
- This represents an unusual presentation of NF, potentially linked to the therapeutic intervention.
Findings:
- The case demonstrates a potential, albeit rare, association between interferon-alpha therapy and the development of necrotizing fasciitis.
- This finding warrants consideration of NF in patients with similar treatment regimens presenting with severe soft tissue infections.
- The specific mechanisms linking interferon-alpha to NF in this context require further investigation.
Implications:
- Clinicians should maintain a high index of suspicion for NF in patients treated with interferon-alpha, especially those with risk factors.
- Further research may elucidate the pathogenetic links between interferon-alpha and NF.
- This case underscores the importance of comprehensive patient monitoring during antiviral therapies.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Viral Hepatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cytomegalovirus Disease